Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

NanoString to Present at the Stifel 2019 Healthcare Conference


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company's management is scheduled to present at the Stifel 2019 Healthcare Conference in New York City.

Brad Gray, president and chief executive officer, is scheduled to present on Wednesday, November 20th, 2019 from 1:15-1:45pm ET. Interested parties can access the live webcast with accompanying slides from the investor section of the company's website at www.nanostring.com. The webcast replay will be available one hour after the conclusion of the live presentation and archived for 60 days.

About NanoString Technologies, Inc.

NanoString Technologies is a leading provider of life science tools for translational research and molecular diagnostic products. The company's nCounter® Analysis System is used in life sciences research and has been cited in more than 2,800 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company's GeoMxtm Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections. The company's technology is also being used in diagnostics. The Prosigna® Breast Cancer Prognostic Gene Signature Assay together with the nCounter Dx Analysis System is FDA 510(k) cleared for use as a prognostic indicator for distant recurrence of breast cancer.

For more information, please visit www.nanostring.com.

NanoString, NanoString Technologies, the NanoString logo, nCounter and Prosigna are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.


These press releases may also interest you

at 22:58
One-day mobile collections for COVID-19 testing specimens are continuing this weekend and into early next week, with the University of Mississippi Medical Center, Mississippi State Department of Health, Mississippi Emergency Management Agency and...

at 22:10
CureApp, Inc. (Head Office, Chuo-ku, Tokyo; President and CEO, Kohta Satake, M.D.), developer of software as a medical device "Digital Therapeutics" mobile applications, has launched a Phase 3 multicenter, randomized comparative study (clinical...

at 21:45
LiveShop Inc., an e-commerce platform to enable local shops to sell easily to their local buyers, has decided to offer their platform to all sellers in the U.S. and U.K. Company announcement: With social distancing and stay-at-home directives in...

at 20:05
Technavio has been monitoring the artificial intelligence (AI) in construction market and it is poised to grow by USD 1.13 billion during 2019-2023. The report offers an up-to-date analysis regarding the current market scenario, latest trends and...

at 19:30
The "Loudspeakers Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering. This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares,...

at 19:30
Trepp, a leading provider of information, analytics, and solutions to the structured finance, commercial real estate (CRE), and banking markets has released its quarterly report of bank portfolio loan performance in commercial real estate,...



News published on 13 november 2019 at 16:05 and distributed by: